Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...
HOUSTON, Dec. 3, 2025 /PRNewswire/ -- Avance Biosciences today announced the opening of its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and ...
RESEARCH TRIANGLE PARK, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics, a clinical-stage biopharmaceutical company focused on advancing innovative biologic drug therapies for chronic ...
(MENAFN- EIN Presswire) EINPresswire/ -- TheraDep Technologies Inc. (“TheraDep”), a next-generation life-sciences biologic-coating and surface-functionalization company, today announced the ...
This article and associated images are based on a poster originally authored by Sriram Kumaraswamy, Benjamin Osborn, Rich Wang and Indrani Chakraborty and presented at ELRIG Drug Discovery 2025 in ...
A new class of cancer drug has been pushed to an almost unimaginable level of potency in the lab, with researchers reporting a 20,000‑fold jump in tumor‑killing power while aiming to spare healthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback